Usefulness of Updated Valve Academic Research Consortium–2 Criteria for Acute Kidney Injury Following Transcatheter Aortic Valve Implantation
Acute kidney injury (AKI) after transcatheter aortic valve implantation (TAVI) is frequent and associated with adverse outcomes. We aimed to identify the incidence and risk factors for AKI after TAVI using the updated Valve Academic Research Consortium–2 classification criteria. We performed a retro...
Gespeichert in:
| Veröffentlicht in: | The American journal of cardiology 2013-12, Vol.112 (11), p.1807-1811 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1811 |
|---|---|
| container_issue | 11 |
| container_start_page | 1807 |
| container_title | The American journal of cardiology |
| container_volume | 112 |
| creator | Konigstein, Maayan, MD Ben-Assa, Eyal, MD Abramowitz, Yigal, MD Steinvil, Arie, MD, MHA Leshem Rubinow, Eran, MD, MHA Havakuk, Ofer, MD Arbel, Yaron, MD Halkin, Amir, MD Keren, Gad, MD Banai, Shmuel, MD Finkelstein, Ariel, MD |
| description | Acute kidney injury (AKI) after transcatheter aortic valve implantation (TAVI) is frequent and associated with adverse outcomes. We aimed to identify the incidence and risk factors for AKI after TAVI using the updated Valve Academic Research Consortium–2 classification criteria. We performed a retrospective analysis of 300 consecutive patients undergoing TAVI using either Edwards SAPIEN XT or CoreValve bioprostheses at our medical center. Change in serum creatinine from base line to 48 to 72 hours after TAVI was used to define AKI stages 1 to 3. The final study cohort included 251 patients. Overall incidence of AKI was 16.7% (42 of 251); of which, stage 1 AKI was 15.1% (38 of 251), stage 2 AKI was 1.6% (4 of 251), and none had stage 3 AKI or required hemodialysis. All-cause mortality at 30 days and 1 year was greater among patients with AKI (9.5% vs 1%, p |
| doi_str_mv | 10.1016/j.amjcard.2013.07.048 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1459161614</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914913016755</els_id><sourcerecordid>1459161614</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-71c62acbc1ab1726cd1a0b423510c3843ef0a0149e3714e6d6f6ec7a601c63f73</originalsourceid><addsrcrecordid>eNqFksGO0zAQhi0EYsvCI4AsceHS4IkdJ7mAqoqFipWQYMvVcp0J65DYXTtZ1BtvwIE35Elw1ALSXpAPlqXv_z0z_xDyFFgGDOTLLtNDZ3RospwBz1iZMVHdIwuoynoJNfD7ZMEYy5c1iPqMPIqxS0-AQj4kZ7lgkLNcLMiPbcR26h3GSH1Lt_tGj9jQz7q_RboyusHBGvoRI-pgrunau-jDaKfh1_efOV0HO2KwmrY-JHoakb63jcMD3bhuCgd64fvef7PuC70K2kWjx2tMCrqaTczpm82w77Ub9Wi9e0wetLqP-OR0n5PtxZur9bvl5Ye3m_XqcmmEqMZlCUbm2uwM6B2UuTQNaLYTOS-AGV4Jji3TLHWOvASBspGtRFNqyZKQtyU_Jy-OvvvgbyaMoxpsNNinQtBPUYEoapDpiIQ-v4N2fgouVZcoKeoqzVUmqjhSJvgYA7ZqH-ygw0EBU3NiqlOnxNScmGKlSokl3bOT-7QbsPmr-hNRAl4fAUzjuLUYVDQWncHGBjSjarz97xev7jiY3jprdP8VDxj_daNirpj6NK_NvDXAk2dZFPw3qCnAhw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1464980006</pqid></control><display><type>article</type><title>Usefulness of Updated Valve Academic Research Consortium–2 Criteria for Acute Kidney Injury Following Transcatheter Aortic Valve Implantation</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Konigstein, Maayan, MD ; Ben-Assa, Eyal, MD ; Abramowitz, Yigal, MD ; Steinvil, Arie, MD, MHA ; Leshem Rubinow, Eran, MD, MHA ; Havakuk, Ofer, MD ; Arbel, Yaron, MD ; Halkin, Amir, MD ; Keren, Gad, MD ; Banai, Shmuel, MD ; Finkelstein, Ariel, MD</creator><creatorcontrib>Konigstein, Maayan, MD ; Ben-Assa, Eyal, MD ; Abramowitz, Yigal, MD ; Steinvil, Arie, MD, MHA ; Leshem Rubinow, Eran, MD, MHA ; Havakuk, Ofer, MD ; Arbel, Yaron, MD ; Halkin, Amir, MD ; Keren, Gad, MD ; Banai, Shmuel, MD ; Finkelstein, Ariel, MD</creatorcontrib><description>Acute kidney injury (AKI) after transcatheter aortic valve implantation (TAVI) is frequent and associated with adverse outcomes. We aimed to identify the incidence and risk factors for AKI after TAVI using the updated Valve Academic Research Consortium–2 classification criteria. We performed a retrospective analysis of 300 consecutive patients undergoing TAVI using either Edwards SAPIEN XT or CoreValve bioprostheses at our medical center. Change in serum creatinine from base line to 48 to 72 hours after TAVI was used to define AKI stages 1 to 3. The final study cohort included 251 patients. Overall incidence of AKI was 16.7% (42 of 251); of which, stage 1 AKI was 15.1% (38 of 251), stage 2 AKI was 1.6% (4 of 251), and none had stage 3 AKI or required hemodialysis. All-cause mortality at 30 days and 1 year was greater among patients with AKI (9.5% vs 1%, p <0.01% and 25.7% vs 12.3%, p = 0.041, respectively). Despite greater volume of contrast media used in Edwards SAPIEN versus CoreValve (162 ml vs 142 ml, p = 0.02), there was no difference in the incidence of AKI between the 2 valve types (23.7% vs 15.5%, p = 0.238) or when comparing larger (29 to 31 mm) versus smaller size valves (23 to 26 mm; 17.7% vs 16.1%, p = 0.745). AKI was associated with chronic kidney disease, history of peripheral vascular disease, blood transfusion, and higher EuroSCORE (p <0.05 for all). In conclusion, according to the new Valve Academic Research Consortium–2 classification, 1 in every 6 patients in our cohort developed AKI after TAVI (most were stage 1 AKI). AKI was associated with increased mortality. No difference in AKI incidence was observed between different types and sizes of bioprostheses used.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2013.07.048</identifier><identifier>PMID: 24012024</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acute Kidney Injury - blood ; Acute Kidney Injury - diagnosis ; Acute Kidney Injury - epidemiology ; Acute Kidney Injury - etiology ; Aged ; Aged, 80 and over ; Aortic Valve - surgery ; Aortic Valve Stenosis - surgery ; Blood transfusions ; Cardiac Catheterization ; Cardiovascular ; Cardiovascular disease ; Chronic obstructive pulmonary disease ; Classification ; Cohort Studies ; Confidence intervals ; Contrast agents ; Contrast Media ; Coronary vessels ; Creatinine - blood ; Diabetes Mellitus - epidemiology ; Female ; Heart attacks ; Heart Failure - epidemiology ; Heart Valve Prosthesis Implantation - adverse effects ; Humans ; Hydration ; Hypertension - epidemiology ; Kidney diseases ; Logistic Models ; Male ; Mens health ; Mortality ; Multivariate Analysis ; Myocardial Infarction - epidemiology ; Peripheral Vascular Diseases - epidemiology ; Proportional Hazards Models ; Prostheses ; Renal Insufficiency, Chronic - epidemiology ; Retrospective Studies ; Risk Factors ; Studies ; Variables</subject><ispartof>The American journal of cardiology, 2013-12, Vol.112 (11), p.1807-1811</ispartof><rights>Elsevier Inc.</rights><rights>2013 Elsevier Inc.</rights><rights>Copyright © 2013 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Dec 1, 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c448t-71c62acbc1ab1726cd1a0b423510c3843ef0a0149e3714e6d6f6ec7a601c63f73</citedby><cites>FETCH-LOGICAL-c448t-71c62acbc1ab1726cd1a0b423510c3843ef0a0149e3714e6d6f6ec7a601c63f73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1464980006?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24012024$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Konigstein, Maayan, MD</creatorcontrib><creatorcontrib>Ben-Assa, Eyal, MD</creatorcontrib><creatorcontrib>Abramowitz, Yigal, MD</creatorcontrib><creatorcontrib>Steinvil, Arie, MD, MHA</creatorcontrib><creatorcontrib>Leshem Rubinow, Eran, MD, MHA</creatorcontrib><creatorcontrib>Havakuk, Ofer, MD</creatorcontrib><creatorcontrib>Arbel, Yaron, MD</creatorcontrib><creatorcontrib>Halkin, Amir, MD</creatorcontrib><creatorcontrib>Keren, Gad, MD</creatorcontrib><creatorcontrib>Banai, Shmuel, MD</creatorcontrib><creatorcontrib>Finkelstein, Ariel, MD</creatorcontrib><title>Usefulness of Updated Valve Academic Research Consortium–2 Criteria for Acute Kidney Injury Following Transcatheter Aortic Valve Implantation</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Acute kidney injury (AKI) after transcatheter aortic valve implantation (TAVI) is frequent and associated with adverse outcomes. We aimed to identify the incidence and risk factors for AKI after TAVI using the updated Valve Academic Research Consortium–2 classification criteria. We performed a retrospective analysis of 300 consecutive patients undergoing TAVI using either Edwards SAPIEN XT or CoreValve bioprostheses at our medical center. Change in serum creatinine from base line to 48 to 72 hours after TAVI was used to define AKI stages 1 to 3. The final study cohort included 251 patients. Overall incidence of AKI was 16.7% (42 of 251); of which, stage 1 AKI was 15.1% (38 of 251), stage 2 AKI was 1.6% (4 of 251), and none had stage 3 AKI or required hemodialysis. All-cause mortality at 30 days and 1 year was greater among patients with AKI (9.5% vs 1%, p <0.01% and 25.7% vs 12.3%, p = 0.041, respectively). Despite greater volume of contrast media used in Edwards SAPIEN versus CoreValve (162 ml vs 142 ml, p = 0.02), there was no difference in the incidence of AKI between the 2 valve types (23.7% vs 15.5%, p = 0.238) or when comparing larger (29 to 31 mm) versus smaller size valves (23 to 26 mm; 17.7% vs 16.1%, p = 0.745). AKI was associated with chronic kidney disease, history of peripheral vascular disease, blood transfusion, and higher EuroSCORE (p <0.05 for all). In conclusion, according to the new Valve Academic Research Consortium–2 classification, 1 in every 6 patients in our cohort developed AKI after TAVI (most were stage 1 AKI). AKI was associated with increased mortality. No difference in AKI incidence was observed between different types and sizes of bioprostheses used.</description><subject>Acute Kidney Injury - blood</subject><subject>Acute Kidney Injury - diagnosis</subject><subject>Acute Kidney Injury - epidemiology</subject><subject>Acute Kidney Injury - etiology</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aortic Valve - surgery</subject><subject>Aortic Valve Stenosis - surgery</subject><subject>Blood transfusions</subject><subject>Cardiac Catheterization</subject><subject>Cardiovascular</subject><subject>Cardiovascular disease</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Classification</subject><subject>Cohort Studies</subject><subject>Confidence intervals</subject><subject>Contrast agents</subject><subject>Contrast Media</subject><subject>Coronary vessels</subject><subject>Creatinine - blood</subject><subject>Diabetes Mellitus - epidemiology</subject><subject>Female</subject><subject>Heart attacks</subject><subject>Heart Failure - epidemiology</subject><subject>Heart Valve Prosthesis Implantation - adverse effects</subject><subject>Humans</subject><subject>Hydration</subject><subject>Hypertension - epidemiology</subject><subject>Kidney diseases</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Mens health</subject><subject>Mortality</subject><subject>Multivariate Analysis</subject><subject>Myocardial Infarction - epidemiology</subject><subject>Peripheral Vascular Diseases - epidemiology</subject><subject>Proportional Hazards Models</subject><subject>Prostheses</subject><subject>Renal Insufficiency, Chronic - epidemiology</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Studies</subject><subject>Variables</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFksGO0zAQhi0EYsvCI4AsceHS4IkdJ7mAqoqFipWQYMvVcp0J65DYXTtZ1BtvwIE35Elw1ALSXpAPlqXv_z0z_xDyFFgGDOTLLtNDZ3RospwBz1iZMVHdIwuoynoJNfD7ZMEYy5c1iPqMPIqxS0-AQj4kZ7lgkLNcLMiPbcR26h3GSH1Lt_tGj9jQz7q_RboyusHBGvoRI-pgrunau-jDaKfh1_efOV0HO2KwmrY-JHoakb63jcMD3bhuCgd64fvef7PuC70K2kWjx2tMCrqaTczpm82w77Ub9Wi9e0wetLqP-OR0n5PtxZur9bvl5Ye3m_XqcmmEqMZlCUbm2uwM6B2UuTQNaLYTOS-AGV4Jji3TLHWOvASBspGtRFNqyZKQtyU_Jy-OvvvgbyaMoxpsNNinQtBPUYEoapDpiIQ-v4N2fgouVZcoKeoqzVUmqjhSJvgYA7ZqH-ygw0EBU3NiqlOnxNScmGKlSokl3bOT-7QbsPmr-hNRAl4fAUzjuLUYVDQWncHGBjSjarz97xev7jiY3jprdP8VDxj_daNirpj6NK_NvDXAk2dZFPw3qCnAhw</recordid><startdate>20131201</startdate><enddate>20131201</enddate><creator>Konigstein, Maayan, MD</creator><creator>Ben-Assa, Eyal, MD</creator><creator>Abramowitz, Yigal, MD</creator><creator>Steinvil, Arie, MD, MHA</creator><creator>Leshem Rubinow, Eran, MD, MHA</creator><creator>Havakuk, Ofer, MD</creator><creator>Arbel, Yaron, MD</creator><creator>Halkin, Amir, MD</creator><creator>Keren, Gad, MD</creator><creator>Banai, Shmuel, MD</creator><creator>Finkelstein, Ariel, MD</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20131201</creationdate><title>Usefulness of Updated Valve Academic Research Consortium–2 Criteria for Acute Kidney Injury Following Transcatheter Aortic Valve Implantation</title><author>Konigstein, Maayan, MD ; Ben-Assa, Eyal, MD ; Abramowitz, Yigal, MD ; Steinvil, Arie, MD, MHA ; Leshem Rubinow, Eran, MD, MHA ; Havakuk, Ofer, MD ; Arbel, Yaron, MD ; Halkin, Amir, MD ; Keren, Gad, MD ; Banai, Shmuel, MD ; Finkelstein, Ariel, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-71c62acbc1ab1726cd1a0b423510c3843ef0a0149e3714e6d6f6ec7a601c63f73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Acute Kidney Injury - blood</topic><topic>Acute Kidney Injury - diagnosis</topic><topic>Acute Kidney Injury - epidemiology</topic><topic>Acute Kidney Injury - etiology</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aortic Valve - surgery</topic><topic>Aortic Valve Stenosis - surgery</topic><topic>Blood transfusions</topic><topic>Cardiac Catheterization</topic><topic>Cardiovascular</topic><topic>Cardiovascular disease</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Classification</topic><topic>Cohort Studies</topic><topic>Confidence intervals</topic><topic>Contrast agents</topic><topic>Contrast Media</topic><topic>Coronary vessels</topic><topic>Creatinine - blood</topic><topic>Diabetes Mellitus - epidemiology</topic><topic>Female</topic><topic>Heart attacks</topic><topic>Heart Failure - epidemiology</topic><topic>Heart Valve Prosthesis Implantation - adverse effects</topic><topic>Humans</topic><topic>Hydration</topic><topic>Hypertension - epidemiology</topic><topic>Kidney diseases</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Mens health</topic><topic>Mortality</topic><topic>Multivariate Analysis</topic><topic>Myocardial Infarction - epidemiology</topic><topic>Peripheral Vascular Diseases - epidemiology</topic><topic>Proportional Hazards Models</topic><topic>Prostheses</topic><topic>Renal Insufficiency, Chronic - epidemiology</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Studies</topic><topic>Variables</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Konigstein, Maayan, MD</creatorcontrib><creatorcontrib>Ben-Assa, Eyal, MD</creatorcontrib><creatorcontrib>Abramowitz, Yigal, MD</creatorcontrib><creatorcontrib>Steinvil, Arie, MD, MHA</creatorcontrib><creatorcontrib>Leshem Rubinow, Eran, MD, MHA</creatorcontrib><creatorcontrib>Havakuk, Ofer, MD</creatorcontrib><creatorcontrib>Arbel, Yaron, MD</creatorcontrib><creatorcontrib>Halkin, Amir, MD</creatorcontrib><creatorcontrib>Keren, Gad, MD</creatorcontrib><creatorcontrib>Banai, Shmuel, MD</creatorcontrib><creatorcontrib>Finkelstein, Ariel, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Konigstein, Maayan, MD</au><au>Ben-Assa, Eyal, MD</au><au>Abramowitz, Yigal, MD</au><au>Steinvil, Arie, MD, MHA</au><au>Leshem Rubinow, Eran, MD, MHA</au><au>Havakuk, Ofer, MD</au><au>Arbel, Yaron, MD</au><au>Halkin, Amir, MD</au><au>Keren, Gad, MD</au><au>Banai, Shmuel, MD</au><au>Finkelstein, Ariel, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Usefulness of Updated Valve Academic Research Consortium–2 Criteria for Acute Kidney Injury Following Transcatheter Aortic Valve Implantation</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2013-12-01</date><risdate>2013</risdate><volume>112</volume><issue>11</issue><spage>1807</spage><epage>1811</epage><pages>1807-1811</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>Acute kidney injury (AKI) after transcatheter aortic valve implantation (TAVI) is frequent and associated with adverse outcomes. We aimed to identify the incidence and risk factors for AKI after TAVI using the updated Valve Academic Research Consortium–2 classification criteria. We performed a retrospective analysis of 300 consecutive patients undergoing TAVI using either Edwards SAPIEN XT or CoreValve bioprostheses at our medical center. Change in serum creatinine from base line to 48 to 72 hours after TAVI was used to define AKI stages 1 to 3. The final study cohort included 251 patients. Overall incidence of AKI was 16.7% (42 of 251); of which, stage 1 AKI was 15.1% (38 of 251), stage 2 AKI was 1.6% (4 of 251), and none had stage 3 AKI or required hemodialysis. All-cause mortality at 30 days and 1 year was greater among patients with AKI (9.5% vs 1%, p <0.01% and 25.7% vs 12.3%, p = 0.041, respectively). Despite greater volume of contrast media used in Edwards SAPIEN versus CoreValve (162 ml vs 142 ml, p = 0.02), there was no difference in the incidence of AKI between the 2 valve types (23.7% vs 15.5%, p = 0.238) or when comparing larger (29 to 31 mm) versus smaller size valves (23 to 26 mm; 17.7% vs 16.1%, p = 0.745). AKI was associated with chronic kidney disease, history of peripheral vascular disease, blood transfusion, and higher EuroSCORE (p <0.05 for all). In conclusion, according to the new Valve Academic Research Consortium–2 classification, 1 in every 6 patients in our cohort developed AKI after TAVI (most were stage 1 AKI). AKI was associated with increased mortality. No difference in AKI incidence was observed between different types and sizes of bioprostheses used.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>24012024</pmid><doi>10.1016/j.amjcard.2013.07.048</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9149 |
| ispartof | The American journal of cardiology, 2013-12, Vol.112 (11), p.1807-1811 |
| issn | 0002-9149 1879-1913 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1459161614 |
| source | MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland |
| subjects | Acute Kidney Injury - blood Acute Kidney Injury - diagnosis Acute Kidney Injury - epidemiology Acute Kidney Injury - etiology Aged Aged, 80 and over Aortic Valve - surgery Aortic Valve Stenosis - surgery Blood transfusions Cardiac Catheterization Cardiovascular Cardiovascular disease Chronic obstructive pulmonary disease Classification Cohort Studies Confidence intervals Contrast agents Contrast Media Coronary vessels Creatinine - blood Diabetes Mellitus - epidemiology Female Heart attacks Heart Failure - epidemiology Heart Valve Prosthesis Implantation - adverse effects Humans Hydration Hypertension - epidemiology Kidney diseases Logistic Models Male Mens health Mortality Multivariate Analysis Myocardial Infarction - epidemiology Peripheral Vascular Diseases - epidemiology Proportional Hazards Models Prostheses Renal Insufficiency, Chronic - epidemiology Retrospective Studies Risk Factors Studies Variables |
| title | Usefulness of Updated Valve Academic Research Consortium–2 Criteria for Acute Kidney Injury Following Transcatheter Aortic Valve Implantation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T14%3A00%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Usefulness%20of%20Updated%20Valve%20Academic%20Research%20Consortium%E2%80%932%20Criteria%20for%20Acute%20Kidney%20Injury%20Following%20Transcatheter%20Aortic%20Valve%20Implantation&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Konigstein,%20Maayan,%20MD&rft.date=2013-12-01&rft.volume=112&rft.issue=11&rft.spage=1807&rft.epage=1811&rft.pages=1807-1811&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/j.amjcard.2013.07.048&rft_dat=%3Cproquest_cross%3E1459161614%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1464980006&rft_id=info:pmid/24012024&rft_els_id=S0002914913016755&rfr_iscdi=true |